Clinical Trial Update: Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating non-inferiority of pain intensity after Biomatrop (somatropin) application compared to Hormotrop (somatropin) in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Subjects

Drugs mentioned

• Biomatrop (somatropin)
• Hormotrop (somatropin)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Healthy Subjects | Phase 4 | Status: UNKNOWN